Medicus Sciences Acquisition Corp. (MSAC)
| Market Cap | 101.00M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 10.10M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | n/a |
| Last Price | n/a |
| Previous Close | n/a |
| Change ($) | n/a |
| Change (%) | n/a |
| Day's Open | n/a |
| Day's Range | n/a |
| Day's Volume | n/a |
| 52-Week Range | n/a |
News
Medicus Sciences Acquisition, a blank check company targeting the medical technology sector, filed on Wednesday with the SEC to raise up to $80 million in an initial public offering.
Medicus Sciences Acquisition Corp. has filed to go public with an IPO on the NASDAQ.
About MSAC
Medicus Sciences Acquisition is a newly organized blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. We intend to capitalize on our management team’s background and experience to identify promising opportunities in the medical technology sector. Unlike most other healthcare focused blank check companies, our sponsor is an affiliate of two healthcare-focused investment firms rather than just one. S... [Read more...]
| Industry Blank Checks / SPAC | IPO Date Pending |
| CEO Michael Castor, M.D. | |
| Stock Exchange NASDAQ | Ticker Symbol MSAC |